KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) Revenue (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Revenue for 16 consecutive years, with $18.8 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 24.34% to $18.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $96.2 million through Dec 2025, up 28.89% year-over-year, with the annual reading at $96.2 million for FY2025, 28.89% up from the prior year.
  • Revenue for Q4 2025 was $18.8 million at Biolife Solutions, down from $28.1 million in the prior quarter.
  • The five-year high for Revenue was $40.7 million in Q3 2022, with the low at -$41.3 million in Q4 2022.
  • Average Revenue over 5 years is $22.1 million, with a median of $24.7 million recorded in 2025.
  • The sharpest move saw Revenue surged 214.56% in 2021, then tumbled 210.6% in 2022.
  • Over 5 years, Revenue stood at $37.3 million in 2021, then crashed by 210.6% to -$41.3 million in 2022, then skyrocketed by 66.13% to -$14.0 million in 2023, then soared by 208.1% to $15.1 million in 2024, then rose by 24.34% to $18.8 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $18.8 million, $28.1 million, and $25.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.